This message was sent to ##Email##
|
|
|
|
|
HealthDay News
A newly identified SARS-like virus in bats appears to be able to jump to humans without mutation, new research suggests.
However, it's not yet clear whether it would then be able to spread from person to person, the researchers said.
READ MORE
University of Texas Health Science Center at San Antonio via ScienceDaily
How does a protein called connexin put the clamps on cancer? Researchers have now reported an explanation. In the future, cancer therapies could potentially be based on connexin molecules, the study suggests.
READ MORE
|
Promoted by
|
|
|
|
 |
ASCLS
Early bird pricing for the ASCLS/APHL webinar, Competency Assessment: One Approach for an Automated Chemistry Lab, has been extended until Jan. 9. Take advantage of this fantastic deal, which includes full access to live and archived webinar for only $99! For more information and to register for this event, visit www.ascls.org/webinars. ASCLS members receive a discounted registration rate.
READ MORE
PRODUCT SHOWCASE
University of Southern California via Phys.org
Genome editing techniques for blood stem cells just got better, thanks to a team of researchers at the University of Southern California and Sangamo BioSciences. In an upcoming study in Nature Biotechnology, co-first authors Colin M. Exline, Ph.D., from USC and Jianbin Wang, Ph.D., from Sangamo BioSciences describe a new, more efficient way to edit genes in blood-forming or "hematopoietic" stem and progenitor cells.
READ MORE
Cedars-Sinai via Infection Control Today
A new study sheds light on how treatment of methicillin-resistant Staphylococcus aureus with certain antibiotics can potentially make patients sicker. The findings by Cedars-Sinai scientists, published in the journal Cell Host & Microbe, could have implications for managing the bug, a virulent form of the common staph infection that can be difficult to control.
READ MORE
Johns Hopkins Kimmel Cancer Center via News-Medical.Net
Results of a new laboratory study by Johns Hopkins Kimmel Cancer Center researchers suggests that some rare "missense" mutations in the HER2 gene are apparently not — on their own — capable of causing breast cancer growth or spread. In a related finding, the research team said such mutations, which are found in about five percent of breast cancers, may, thus, also fail to predict response to anti-cancer drugs that target the HER2 gene, unlike the more common alterations of the gene that amplify or overexpress it.
READ MORE
Medical News Today
Using nanotechnology, biomedical engineers have developed a way to enhance natural killer cells in the immune system so they can more effectively seek out and destroy cancer cells in lymph nodes. Successfully tested in mice, should the method work in humans, it could stop cancer using lymph nodes to spread to the rest of the body.
READ MORE
 |
|
Maine Standards Company, LLC Launches VALIDATE® HbA1c For Easier
Calibration Verification / Linearity Testing. VALIDATE® HbA1c is a liquid,
easy-to-use kit that tests linearity for % Glycohemoglobin A1c in a human-whole-blood
base matrix. VALIDATE® virtually eliminates dilutions while maximizing reportable
ranges. Visit www.mainestandards.com or call 1-800-377-9684 for more information.
|
|
Reuters
Women may be less likely to panic or pursue aggressive treatment for a common, noninvasive breast tumor if doctors don't use the word "cancer" to describe the abnormal cells, an Australian study suggests. Researchers focused on a preinvasive malignancy of the breast known as ductal carcinoma in situ that is often detected by mammograms and treated with a mastectomy or with a lumpectomy paired with radiation.
READ MORE
DARK Daily
Researchers in Mexico developed a skin test that could lead to the early diagnosis of Alzheimer's disease and pave the way for new therapies to treat a disease ranked as the sixth leading cause of death in the United States.
For clinical pathologists and medical laboratories, a testing breakthrough would be significant since the Alzheimer's Association predicts that the number of Americans 65 and older with Alzheimer's disease will reach 7.1 million by 2025, a 40 percent increase from today.
READ MORE
 |
|
It’s like having my own Flow cytometry lab at my finger tips. Finally, a simple way to bring flow cytometry CD4 testing in-house. MORE
|
|
University of Utah via Lab Manager
University of Utah chemists devised a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders. "We are one step closer to understanding the underlying chemistry that leads to genetic diseases," says Cynthia Burrows, distinguished professor and chair of chemistry at the university and senior author of a new study published Nov. 6 in the online journal Nature Communications.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
